Roche's Accutane Warning Passes Muster In MDL

Law360, New York (July 24, 2012, 7:01 PM EDT) -- Hoffmann-La Roche Inc. adequately warned an Accutane user about the risk of developing inflammatory bowel disease while on the acne drug, a Florida federal judge overseeing multidistrict litigation ruled Tuesday, a decision that could affect much larger Accutane litigation in New Jersey.

The ruling brings an end to one of the few remaining suits in the federal multidistrict litigation over the drug, which was cut down by U.S. District Judge James S. Moody Jr.'s June 2007 decision to exclude the general causation testimony of an expert...
To view the full article, register now.